BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)

Smallpox drug, Tembexa, receives FDA approval

By

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration Friday approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious...

Malaysia starts Ivermectin trial for high risk COVID-19 patients

By

By NewsDesk  @infectiousdiseasenews Effective pharmacologic treatments for COVID-19 remains a challenge. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed dexamethasone, a steroid,...

Malaysia officials respond to ivermectin ‘miracle drug’ claims

By

By NewsDesk  @infectiousdiseasenews Ivermectin is an anti-parasitic drug mostly used in veterinary medicine, especially treating worm infestations. In April 2020, researchers using laboratory methods...

Ivermectin is highly effective as a safe prophylaxis and treatment for COVID-19: Comprehensive review

By

Peer reviewed by medical experts that included three U.S. government senior scientists and published in the American Journal of Therapeutics, the research is the most comprehensive review of the available...

Lyme disease investigational drug: FDA accepts IND application

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Tarsus Pharmaceuticals, recently announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s Investigational...

Philippines congressman pushes for speeding up Ivermectin trials

By

By Teddy Cambosa The Department of Health (DOH) and the Department of Science and Technology (DOST) must fast-track the clinical trials on the use of the antiparasitic drug Ivermectin, according to Rep....

Neisseria

New antibiotic compound effective against multi-drug resistant gonorrhea in mice

By

A new antibiotic compound clears infection of multi-drug resistant gonorrhea in mice in a single oral dose, according to a new study led by researchers at Penn State and Emory University. The compound...

MRSA: KIMYRSA (oritavancin) receives FDA approval for treatment of ABSSSI

By

Melinta Therapeutics, LLC (Melinta), today announced that the U.S. Food and Drug Administration (FDA) has approved KIMYRSA™ (oritavancin)  for the treatment of adult patients with acute bacterial skin...

Hydroxychloroquine had no effect in treating people with COVID-19: Study

By

A year ago, infectious disease doctor Christine Johnston was leading a study on the use of hydroxychloroquine for the treatment of people with COVID-19. The trial launched at the end of March, when the...

Ivermectin: 5-day course did not significantly improve the time to resolution of mild COVID-19 symptoms

By

According to a study published in JAMA today, researchers from the Centro de Estudios en Infectologia Pediatrica in Cali, Colombia looked at the effect of Ivermectin on time to resolution of symptoms...